Exclusive: Pfizer negotiating 2-3 percent Allergan break-up fee - sources
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500, Dow futures dip as big banks' earnings roll in ahead of CPI data; IBM slides
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- SK Hynix’s record plunge drags down global chip stocks
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- IBM misses Q2 targets as mainframe and software sales disappoint
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
Enanta Pharma (ENTA) Receives $30M Milestone from AbbVie
November 20, 2015 9:06 AM ESTEnanta Pharma (NASDAQ: ENTA) disclosed the following on Friday morning:
Enanta Pharmaceuticals, Inc. has earned a $30 million milestone payment from AbbVie following the recent price reimbursement approval in Japan of AbbVies VIEKIRAX treatment for HCV infection, which had been approved for regulatory... More
New Treasury Guidelines on Inversion May Not Apply to Allergan (AGN)/Pfizer (PFE) - Evercore ISI's Raffat
November 20, 2015 8:33 AM ESTThere's lots of analyst chatter this morning on the pending Allergan (NYSE: AGN), Pfizer (NYSE: PFE) deal amid the... More
